RU94007635A - Комбинированный препарат для контрацепции - Google Patents
Комбинированный препарат для контрацепцииInfo
- Publication number
- RU94007635A RU94007635A RU94007635/14A RU94007635A RU94007635A RU 94007635 A RU94007635 A RU 94007635A RU 94007635/14 A RU94007635/14 A RU 94007635/14A RU 94007635 A RU94007635 A RU 94007635A RU 94007635 A RU94007635 A RU 94007635A
- Authority
- RU
- Russia
- Prior art keywords
- contraception
- estrogen
- progestogen
- biogenic
- synthetic
- Prior art date
Links
- 239000000262 estrogen Substances 0.000 claims 6
- 230000000035 biogenic Effects 0.000 claims 4
- 239000000583 progesterone congener Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Claims (1)
- Настоящее изобретение относится к комбинированному фармацевтическому препарату для контрацепции, состоящему из первой ступени, которая содержит комбинацию из трех компонентов, а именно биогенного эстрогена, синтетического эстрогена и гестагена, а также в случае необходимости одной или нескольких дальнейших ступеней, которые состоят из фармацевтически приемлемого плацебо или биогенного или синтетического гестагена, или биогенного или синтетического эстрогена, или из комбинации трех компонентов, а именно биогенного эстрогена, синтетического эстрогена и гестагена, или комбинации из синтетических эстрогенов и гестагена.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4308406A DE4308406C1 (de) | 1993-03-12 | 1993-03-12 | Kombinationspräparat zur Kontrazeption |
DEP4308406.0 | 1993-03-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94007635A true RU94007635A (ru) | 1995-10-27 |
RU2122854C1 RU2122854C1 (ru) | 1998-12-10 |
Family
ID=6482977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94007635/14A RU2122854C1 (ru) | 1993-03-12 | 1994-03-11 | Комбинированный препарат для контрацепции, фармацевтическая упаковка для контрацепции |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0628312B1 (ru) |
AT (1) | ATE192043T1 (ru) |
DE (2) | DE4308406C1 (ru) |
RU (1) | RU2122854C1 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642219B1 (en) | 1997-11-14 | 2003-11-04 | Akzo Nobel N.V. | Progestogen-antiprogestogen regimens |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4313926A1 (de) * | 1993-04-28 | 1994-11-03 | Jenapharm Gmbh | Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption |
DE4339934C2 (de) * | 1993-05-07 | 1995-05-24 | Klaus Dr Med Umbreit | Ovulationshemmendes Mittel zur hormonalen Kontrazeption |
DE4344405C2 (de) * | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption |
DE4429374C1 (de) | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
DE19534209A1 (de) * | 1995-09-15 | 1997-03-20 | Jenapharm Gmbh | Hormonales Mittel zur Behandlung der Haut |
DE19539233A1 (de) * | 1995-10-21 | 1997-04-24 | Klaus Dr Med Umbreit | Oral einzunehmendes ovulationshemmendes Mittel |
DE19540253C2 (de) * | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
DE19548332A1 (de) * | 1995-12-22 | 1997-07-10 | Rotta Res Bv | Hormonpflaster |
WO1997041868A1 (en) * | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
DK0921804T3 (da) * | 1996-07-26 | 2003-11-24 | Wyeth Corp | Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen |
US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
DE19705229C2 (de) * | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
US7335650B2 (en) | 2000-01-14 | 2008-02-26 | Sterix Limited | Composition |
US6653298B2 (en) | 2000-01-14 | 2003-11-25 | Sterix Limited | Composition |
CA2448270A1 (en) * | 2001-05-23 | 2002-11-28 | Panterhei Bioscience B.V. | Means and method for hormonal contraception |
DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
DE102004026671A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Darreichungsform zur hormonalen Kontrazeption |
DE102004026670A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
US10912762B2 (en) | 2018-03-23 | 2021-02-09 | Laboratoires Major | Non-hormonal compositions and methods for male contraception |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2335265A1 (de) * | 1973-07-09 | 1975-01-30 | Schering Ag | Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten |
DE2431704A1 (de) * | 1974-07-02 | 1976-01-22 | Asche Ag | Stufenkombinationspraeparate per kontrazeption |
DE2645307A1 (de) * | 1976-10-05 | 1978-04-06 | Schering Ag | Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen |
US4372951A (en) * | 1979-10-11 | 1983-02-08 | Nichols Vorys | Vaginal delivery for physiologic follicular-luteal steroid treatment |
US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
-
1993
- 1993-03-12 DE DE4308406A patent/DE4308406C1/de not_active Revoked
-
1994
- 1994-02-14 DE DE59409298T patent/DE59409298D1/de not_active Revoked
- 1994-02-14 AT AT94250030T patent/ATE192043T1/de not_active IP Right Cessation
- 1994-02-14 EP EP94250030A patent/EP0628312B1/de not_active Revoked
- 1994-03-11 RU RU94007635/14A patent/RU2122854C1/ru active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642219B1 (en) | 1997-11-14 | 2003-11-04 | Akzo Nobel N.V. | Progestogen-antiprogestogen regimens |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94007635A (ru) | Комбинированный препарат для контрацепции | |
RU93055882A (ru) | Производные n-сульфонил-2-оксоиндола, способ их получения, исходные для их получения, фармацевтическая композиция на их основе | |
CA2041260A1 (en) | Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents | |
NO891388L (no) | Fremgangsmaate for fremstilling av olefiner ut fra naturgass. | |
NO900031D0 (no) | Fremgangsmaate for fremstilling av olefiner ut fra naturgass. | |
TR199600792A2 (tr) | Dihaloazolopirimidinlerin hazirlanmasina yönelik proses. | |
EA199800692A1 (ru) | Изолируемые смеси из семян eugenia jambolana lamarck, способы их получения, способ получения оксамата натрия, лекарственные средства для профилактики и лечения диабета и применение указанных смесей, их компонентов и оксамата натрия для получения этих лекарственных средств | |
RU94022277A (ru) | Новые 19-норстероиды, имеющие в положении 11 - бета феноксиалкилсульфонамидную или феноксиалкилсульфонилкарбамидную цепь, метод и промежуточные продукты их получения, и содержащая их фармацевтическая композиция | |
IL98262A0 (en) | Chromone derivatives and pharmaceutical compositions containing them | |
NO895176D0 (no) | Fremgangsmaate ved fremstilling av mono-n-alkylerte polyazamakrocykler. | |
WO1999014241A3 (en) | Compositions and methods for the treatment of immune related diseases | |
ZA978351B (en) | Immunogenic peptides of foot-and-mouth disease viruses. | |
CA2238278A1 (en) | Antigenic protein originating in malassezia | |
NO904318L (no) | Fremgangsmaate for fremstilling av en aluminium-strontium-forlegering. | |
NO905029L (no) | Fremgangsmaate for fremstilling av steroider. | |
HUP9702480A3 (en) | New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same | |
DE59704199D1 (de) | Kohlenhydratderivate und ihre synthese an fester phase | |
NO913396D0 (no) | Fremgangsmaate for fremstilling av peptider ved fastfasesyntese. | |
TR200002293T2 (tr) | Farmasötik bileşimler. | |
NO900873D0 (no) | Fremgangsmaate ved fremstilling av sekundaert alkylamin. | |
CA2169696A1 (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
DE69635990D1 (de) | Bromierte hexahydroxybiphenylderivate | |
HUP9702479A3 (en) | New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same | |
AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
CA2165418A1 (en) | Anti-inflammatory peptides |